Consistent with our previous conclusion, these oncogenic pathways were related to the non-inflamed TME in BLCA, which meant that the inflammation level of TME in the high-PMEPA1 group was higher than the low-PMEPA1 group,. This evidence concerns the gene PMEPA1 and bladder transitional cell carcinoma.